abstract |
Use of an immunogenic composition comprising VZV gE or an immunogenic fragment thereof and a TH-1 adjuvant in the manufacture of a medicament for the prevention or amelioration of herpes zoster and / or postherpetic neuralgia. Also claimed is a composition comprising a truncated VZV gE and an adjuvant comprising QS21, cholesterol and 3D MPL. [Selection figure] None |